Elaprase monograph
WebELAPRASE ® (Idursulfase) is indicated for patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II). ELAPRASE has been shown to improve walking … WebMay 16, 2007 · Idursulfase is a purified form of human iduronate-2-sulfatase, a lysosomal enzyme. Idursulfase is produced by recombinant DNA technology in a human cell line. Idursulfase is an enzyme that hydrolyzes the 2-sulfate esters of terminal iduronate sulfate residues from the glycosaminoglycans dermatan sulfate and heparan sulfate in the …
Elaprase monograph
Did you know?
WebElaprase (idursulfase) dosing, indications, interactions, adverse effects, and more Drugs & Diseases idursulfase (Rx) Brand and Other Names: Elaprase Classes: Enzymes, … WebProduct Monograph. CUVITRU® Normal Immunoglobulin (Human) Product Monograph. DEXILANT ® dexlansoprazole. Product Monograph: ELAPRASE ® idursulfase for …
WebELAPRASE has been shown to improve walking capacity in patients 5 years and older.In patients 16 months to 5 years of age, no data are available to demonstrate improvement … WebElaprase is indicated for the long-term treatment of patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II). Heterozygous females were not studied in the clinical trials. 4.2 Posology and method of administration This treatment should be supervised by a physician or other healthcare professional experienced in the
WebELAPRASE. IDURSULFASE (EYE dur SUL fase) is used to replace an enzyme that is missing in patients with Hunter syndrome. It is not a cure. ELAPRASE Monographs. … WebIndications and Usage. ELAPRASE ® (Idursulfase) is indicated for patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II). ELAPRASE has been shown to improve walking capacity in patients 5 years and older. In patients 16 months to 5 years of age, no data are available to demonstrate improvement in disease-related symptoms or long term ...
WebELAPRASE is a purified form of the lysosomal enzyme iduronate-2-sulfatase and is produced by recombinant DNA technology in a human cell line. In conjunction with the market approval of ELAPRASE, Shire Human Genetic Therapies (the Shire business unit focused on genetic diseases) has introduced a new product support center called …
WebSep 27, 2024 · The main aim of this study is to learn more about the safety profile of Elaprase in Indian children and adults with hunter syndrome. Participants will receive Elaprase once per week over a 3-hour period which can be reduced to 1 hour as determined by the study doctor. Participants will need to visit the clinic weekly during the … the numbats showWebIndications and Usage ELAPRASE ® (Idursulfase) is indicated for patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II). ELAPRASE has been shown to improve walking capacity in patients 5 years and older. In patients 16 months to 5 years of age, no data are available to demonstrate improvement in disease-related symptoms or long … the number 00101110 when converted to bcd isWebDrug Names # A B C D E F G H the number 01234 are calledWebOct 1, 2024 · Prepare and use Elaprase according to the following steps using aseptic technique: Determine the total volume of Elaprase to be administered and the number of … the numbed man backroomsWebJul 24, 2006 · Drug Review Package. 10903 New Hampshire Avenue Silver Spring, MD 20993 Ph. 1-888-INFO-FDA (1-888-463-6332) Contact FDA the numbat dietWebFeb 11, 2024 · ELAPRASE® Product Monograph Page 1 of 31. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . Pr ELAPRASE® idursulfase for … the numbed manWebIdursulfase (brand name Elaprase), manufactured by Takeda, is a drug used to treat Hunter syndrome (also called MPS-II). It is a purified form of the lysosomal enzyme iduronate-2 … the number 0 in the point b 0 5 is called the